- Booz Allen Hamilton Holding Corporation (NYSE:BAH) shares are trading high after reporting solid fourth-quarter FY23 results.
- The company saw Q4 sales growth of 8.7% year-on-year to $2.43 billion, beating the consensus of $2.39 billion.
- Revenue, excluding billable expenses, grew 7.1%.
- Adjusted EPS of $1.01 topped the consensus of $0.95.
- Adjusted EBITDA margin expanded by 30 bps to 9.5%.
- Booz Allen Hamilton’s free cash flow was $212.42 million. The backlog increased by 6.7% Y/Y to $31.2 billion.
- Dividend: The company declared a regular quarterly dividend of $0.47 per share, payable on June 30, 2023, to stockholders of record on June 15, 2023.
- The company held $404.86 million in cash and equivalents.
- FY24 Outlook: Booz Allen Hamilton issued FY24 Outlook.
- The company sees sales growth to 7% – 11%. It expects an adjusted EPS of $4.80–$4.95 vs. the consensus of $4.88.
- Price Action: BAH shares traded higher by 6.28% at $95.49 on the last check Friday.
Veracyte Announces Data From 14 Studies Presented At AUA 2024 Show Decipher Tests’ Ability To Help Personalize Care For Prostate And Bladder Cancer Patients And Advance Disease Understanding
Large number of abstracts also showcases power of the Veracyte Diagnostics PlatformVeracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the
